Navalign, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Navalign, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$238,907
-36.2%
75,3650.0%0.09%
-38.9%
Q2 2023$374,564
+0.6%
75,3650.0%0.15%
-4.5%
Q1 2023$372,303
-21.5%
75,3650.0%0.16%
-20.0%
Q4 2022$474,046
-41.8%
75,3650.0%0.20%
-46.7%
Q3 2022$814,000
-5.2%
75,3650.0%0.37%
-2.4%
Q2 2022$859,000
+37.9%
75,365
+1.5%
0.38%
+42.6%
Q1 2022$623,000
-35.2%
74,271
+15.3%
0.26%
-31.5%
Q4 2021$961,000
-42.0%
64,4280.0%0.38%
-45.2%
Q3 2021$1,656,000
-1.4%
64,4280.0%0.70%
-1.5%
Q2 2021$1,680,00064,4280.71%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders